Literature DB >> 29243112

The role of PSMA PET scans in salvage therapy planning.

S Goonewardene1, M Alsheikh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29243112     DOI: 10.1007/s00345-017-2149-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  4 in total

1.  68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.

Authors:  Gregor Habl; Katharina Sauter; Kilian Schiller; Sabrina Dewes; Tobias Maurer; Matthias Eiber; Stephanie E Combs
Journal:  Prostate       Date:  2017-03-20       Impact factor: 4.104

2.  Clinical impact of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach.

Authors:  Simone Albisinni; Carlos Artigas; Fouad Aoun; Ibrahim Biaou; Julien Grosman; Thierry Gil; Eric Hawaux; Ksenija Limani; Francois-Xavier Otte; Alexandre Peltier; Spyridon Sideris; Nicolas Sirtaine; Patrick Flamen; Roland van Velthoven
Journal:  BJU Int       Date:  2017-01-04       Impact factor: 5.588

3.  Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.

Authors:  Louise Emmett; Pim J van Leeuwen; Rohan Nandurkar; Matthijs J Scheltema; Thomas Cusick; George Hruby; Andrew Kneebone; Thomas Eade; Gerald Fogarty; Raj Jagavkar; Quoc Nguyen; Bao Ho; Anthony M Joshua; Phillip Stricker
Journal:  J Nucl Med       Date:  2017-07-26       Impact factor: 10.057

4.  Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after 68Ga-PSMA-PET imaging.

Authors:  Kilian Schiller; K Sauter; S Dewes; M Eiber; T Maurer; J Gschwend; S E Combs; G Habl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-23       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.